Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 10, 2018
Patent Application Number
15518895
Date Filed
October 15, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
